Alastair M. Buchan, Dsc FRCP - Publications

Affiliations: 
Nuffield Department of Clinical Medicine University of Oxford, Oxford, United Kingdom 
Area:
Stroke

187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ovseiko PV, Edmunds LD, Pololi LH, Greenhalgh T, Kiparoglou V, Henderson LR, Williamson C, Grant J, Lord GM, Channon KM, Lechler RI, Buchan AM. Markers of achievement for assessing and monitoring gender equity in translational research organisations: a rationale and study protocol. Bmj Open. 6: e009022. PMID 26743702 DOI: 10.1136/Bmjopen-2015-009022  0.56
2016 DeLuca GC, Ovseiko PV, Buchan AM. Personalized medical education: Reappraising clinician-scientist training Science Translational Medicine. 8. DOI: 10.1126/Scitranslmed.Aad0689  0.56
2015 Sutherland BA, Neuhaus AA, Couch Y, Balami JS, DeLuca GC, Hadley G, Harris SL, Grey AN, Buchan AM. The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661175 DOI: 10.1177/0271678X15606722  0.56
2015 Buchan AM, Karbalai HG, Sutherland BA. The future of stroke therapy must not be mired by past arguments The Lancet. 386: 654. PMID 26334159 DOI: 10.1016/S0140-6736(15)61503-3  0.56
2015 Balami JS, Sutherland BA, Edmunds LD, Grunwald IQ, Neuhaus AA, Hadley G, Karbalai H, Metcalf KA, DeLuca GC, Buchan AM. A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 26310289 DOI: 10.1111/Ijs.12618  0.56
2015 Ovseiko PV, Melham K, Fowler J, Buchan AM. Organisational culture and post-merger integration in an academic health centre: a mixed-methods study. Bmc Health Services Research. 15: 25. PMID 25608775 DOI: 10.1186/S12913-014-0673-3  0.56
2015 Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Reply: Intravenous thrombolysis for ischaemic strokes: A call for reappraisal Brain. 138: e342. PMID 25281865 DOI: 10.1093/Brain/Awu283  0.56
2015 Redzic ZB, Rabie T, Sutherland BA, Buchan AM. Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation International Journal of Stroke. 10: 407-414. DOI: 10.1111/Ijs.12197  0.56
2014 Ovseiko PV, O'Sullivan C, Powell SC, Davies SM, Buchan AM. Implementation of collaborative governance in cross-sector innovation and education networks: evidence from the National Health Service in England. Bmc Health Services Research. 14: 552. PMID 25380727 DOI: 10.1186/S12913-014-0552-Y  0.56
2014 Ovseiko PV, Jenkinson C, Buchan AM. Medical education leaders' perceptions of postgraduate medical education reform The Lancet. 384: 306-307. PMID 25066157 DOI: 10.1016/S0140-6736(14)61239-3  0.56
2014 Chen RL, Ogunshola OO, Yeoh KK, Jani A, Papadakis M, Nagel S, Schofield CJ, Buchan AM. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice. Journal of Neurochemistry. PMID 24974727 DOI: 10.1111/Jnc.12804  0.56
2014 Ovseiko PV, Davies SM, Buchan AM. AM last page: funding of academic research in clinical medicine in the United Kingdom. Academic Medicine : Journal of the Association of American Medical Colleges. 89: 830. PMID 24781301 DOI: 10.1097/Acm.0000000000000219  0.56
2014 Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Reply: Thrombolysis in acute ischaemic stroke Brain. 137: e282. PMID 24727568 DOI: 10.1093/Brain/Awu066  0.56
2014 Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM, Lauritzen M, Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 508: 55-60. PMID 24670647 DOI: 10.1038/Nature13165  0.56
2014 Neuhaus AA, Rabie T, Sutherland BA, Papadakis M, Hadley G, Cai R, Buchan AM. Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke Jama Neurology. 71: 634-639. PMID 24590416 DOI: 10.1001/Jamaneurol.2013.6299  0.56
2014 Sutherland BA, Rabie T, Buchan AM. Laser doppler flowmetry to measure changes in cerebral blood flow Methods in Molecular Biology. 1135: 237-248. PMID 24510869 DOI: 10.1007/978-1-4939-0320-7_20  0.56
2014 Ovseiko PV, Heitmueller A, Allen P, Davies SM, Wells G, Ford GA, Darzi A, Buchan AM. Improving accountability through alignment: the role of academic health science centres and networks in England. Bmc Health Services Research. 14: 24. PMID 24438592 DOI: 10.1186/1472-6963-14-24  0.56
2014 Sutherland BA, Buchan AM. The life of Bo K. Siesjö, MD, PhD, 1930-2013 International Journal of Stroke. 9: 2-4. PMID 24350869 DOI: 10.1111/Ijs.12237  0.56
2014 Young CC, Al-Dalahmah O, Lewis NJ, Brooks KJ, Jenkins MM, Poirier F, Buchan AM, Szele FG. Blocked angiogenesis in Galectin-3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke. Neurobiology of Disease. 63: 155-64. PMID 24269916 DOI: 10.1016/J.Nbd.2013.11.003  0.56
2014 Hadley G, Papadakis M, Buchan AM. A method of inducing global cerebral ischemia Methods in Molecular Biology. 1135: 111-120. DOI: 10.1007/978-1-4939-0320-7_10  0.56
2013 Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. The exact science of stroke thrombolysis and the quiet art of patient selection Brain. 136: 3528-3553. PMID 24038074 DOI: 10.1093/Brain/Awt201  0.56
2013 Sutherland BA, Buchan AM. Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat Journal of Cerebral Blood Flow and Metabolism. 33: E1-E7. PMID 23963368 DOI: 10.1038/Jcbfm.2013.148  0.56
2013 Hadley G, De Luca GC, Papadakis M, Buchan AM. Endogenous neuroprotection: Hamartin modulates an austere approach to staying alive in a recession International Journal of Stroke. 8: 449-450. PMID 23879750 DOI: 10.1111/Ijs.12130  0.56
2013 Papadakis M, Hadley G, Xilouri M, Hoyte LC, Nagel S, McMenamin MM, Tsaknakis G, Watt SM, Drakesmith CW, Chen R, Wood MJ, Zhao Z, Kessler B, Vekrellis K, Buchan AM. Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nature Medicine. 19: 351-7. PMID 23435171 DOI: 10.1038/Nm.3097  0.56
2013 Balami JS, Sutherland BA, Buchan AM. Complications associated with recombinant tissue plasminogen activator therapy for acute Ischaemic stroke Cns and Neurological Disorders - Drug Targets. 12: 155-169. PMID 23394532 DOI: 10.2174/18715273112119990050  0.56
2013 Balami JS, Chen R, Sutherland BA, Buchan AM. Thrombolytic agents for acute ischaemic stroke treatment: The past, present and future Cns and Neurological Disorders - Drug Targets. 12: 145-154. PMID 23394531 DOI: 10.2174/18715273113129990057  0.56
2013 Hill MD, Kenney C, Dzialowski I, Boulanger JM, Demchuk AM, Barber PA, Watson TW, Weir NU, Buchan AM. Tissue Window in Stroke Thrombolysis study (TWIST): a safety study. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 17-20. PMID 23250122 DOI: 10.1017/S0317167100012890  0.56
2013 Young CC, van der Harg JM, Lewis NJ, Brooks KJ, Buchan AM, Szele FG. Ependymal ciliary dysfunction and reactive astrocytosis in a reorganized subventricular zone after stroke. Cerebral Cortex (New York, N.Y. : 1991). 23: 647-59. PMID 22414771 DOI: 10.1093/Cercor/Bhs049  0.56
2013 Balami JS, Chen RL, Buchan AM. Stroke syndromes and clinical management Qjm. 106: 607-615. DOI: 10.1093/Qjmed/Hct057  0.56
2012 Ovseiko PV, Oancea A, Buchan AM. Assessing research impact in academic clinical medicine: A study using Research Excellence Framework pilot impact indicators Bmc Health Services Research. 12. PMID 23259467 DOI: 10.1186/1472-6963-12-478  0.56
2012 Nagel S, Hadley G, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S, Papadakis M. Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia Journal of Neurochemistry. 123: 98-107. PMID 23050647 DOI: 10.1111/J.1471-4159.2012.07948.X  0.56
2012 Chen RL, Nagel S, Papadakis M, Bishop T, Pollard P, Ratcliffe PJ, Pugh CW, Buchan AM. Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice Journal of Physiology. 590: 4079-4091. PMID 22615432 DOI: 10.1113/Jphysiol.2012.232884  0.56
2012 Ovseiko PV, Buchan AM. Organizational culture in an academic health center: An exploratory study using a competing values framework Academic Medicine. 87: 709-718. PMID 22534590 DOI: 10.1097/Acm.0B013E3182537983  0.56
2012 Rothwell PM, Buchan AM. Mobile acute stroke units: bringing the hospital to the patient. The Lancet. Neurology. 11: 382-3. PMID 22497930 DOI: 10.1016/S1474-4422(12)70069-8  0.56
2012 Dzialowski I, Puetz V, Buchan AM, Demchuk AM, Hill MD. Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients? Stroke. 43: 1567-1571. PMID 22496336 DOI: 10.1161/Strokeaha.112.651737  0.56
2012 Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside International Journal of Stroke. 7: 407-418. PMID 22394615 DOI: 10.1111/J.1747-4949.2012.00770.X  0.56
2012 Nagel S, Papadakis M, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S. Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia Neuroscience. 208: 109-122. PMID 22366221 DOI: 10.1016/J.Neuroscience.2012.01.048  0.56
2012 Balami JS, Buchan AM. Complications of intracerebral haemorrhage The Lancet Neurology. 11: 101-118. PMID 22172625 DOI: 10.1016/S1474-4422(11)70264-2  0.56
2012 Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: Current status and future perspectives International Journal of Molecular Sciences. 13: 11753-11772. DOI: 10.3390/Ijms130911753  0.56
2012 Montagu A, Reckless IP, Buchan AM. Stroke: Management and prevention Medicine (United Kingdom). 40: 490-499. DOI: 10.1016/J.Mpmed.2016.06.003  0.56
2011 Ovseiko PV, Buchan AM. Postgraduate medical education in England: 100 years of solitude The Lancet. 378: 1984-1985. PMID 22153191 DOI: 10.1016/S0140-6736(11)61844-8  0.56
2011 Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke The Lancet Neurology. 10: 357-371. PMID 21247806 DOI: 10.1016/S1474-4422(10)70313-6  0.56
2011 Grunwald IQ, Wakhloo AK, Walter S, Molyneux AJ, Byrne JV, Nagel S, Kühn AL, Papadakis M, Fassbender K, Balami JS, Roffi M, Sievert H, Buchan A. Endovascular stroke treatment today. Ajnr. American Journal of Neuroradiology. 32: 238-43. PMID 21233233 DOI: 10.3174/Ajnr.A2346  0.56
2011 Shobha N, Buchan AM, Hill MD. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset - Evidence from the Canadian alteplase for stroke effectiveness study (CASES) registry Cerebrovascular Diseases. 31: 223-228. PMID 21178345 DOI: 10.1159/000321893  0.56
2011 Young CC, Brooks KJ, Buchan AM, Szele FG. Cellular and molecular determinants of stroke-induced changes in subventricular zone cell migration. Antioxidants & Redox Signaling. 14: 1877-88. PMID 20673127 DOI: 10.1089/Ars.2010.3435  0.56
2011 Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C, Buchan AM. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 132-43. PMID 20407463 DOI: 10.1038/Jcbfm.2010.60  0.56
2011 Sutherland BA, Papadakis M, Chen RL, Buchan AM. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia Journal of Physiology. 589: 4105-4114. DOI: 10.1113/Jphysiol.2011.209601  0.56
2010 Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 468: 232-43. PMID 21068832 DOI: 10.1038/Nature09613  0.56
2010 Harston GWJ, Sutherland BA, Kennedy J, Buchan AM. The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: A review of rtPA neurotoxicity Journal of Cerebral Blood Flow and Metabolism. 30: 1804-1816. PMID 20736961 DOI: 10.1038/Jcbfm.2010.149  0.56
2010 Ovseiko PV, Davies SM, Buchan AM. Organizational models of emerging academic health science centers in England Academic Medicine. 85: 1282-1289. PMID 20671453 DOI: 10.1097/Acm.0B013E3181E541Bd  0.56
2010 Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. International Journal of Stroke : Official Journal of the International Stroke Society. 5: 238-56. PMID 20636706 DOI: 10.1111/j.1747-4949.2010.00442.x  0.56
2010 Mateen FJ, Buchan AM, Hill MD. Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians Stroke. 41: 1833-1835. PMID 20576948 DOI: 10.1161/Strokeaha.110.586438  0.56
2010 Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. Cerebrovascular Diseases (Basel, Switzerland). 30: 127-47. PMID 20516682 DOI: 10.1159/000315099  0.56
2010 Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. Stroke; a Journal of Cerebral Circulation. 41: 1084-99. PMID 20498453 DOI: 10.1161/Strokeaha.110.586156  0.56
2010 Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: An overview of evidence Nature Reviews Neurology. 6: 256-265. PMID 20368741 DOI: 10.1038/Nrneurol.2010.36  0.56
2010 Geraghty OC, Kennedy J, Chandratheva A, Marquardt L, Buchan AM, Rothwell PM. Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naïve patients in the acute phase after TIA or minor ischaemic stroke. Cerebrovascular Diseases (Basel, Switzerland). 29: 460-7. PMID 20299785 DOI: 10.1159/000297961  0.56
2010 Hoyte LC, Brooks KJ, Nagel S, Akhtar A, Chen R, Mardiguian S, McAteer MA, Anthony DC, Choudhury RP, Buchan AM, Sibson NR. Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1178-87. PMID 20087364 DOI: 10.1038/Jcbfm.2009.287  0.56
2010 Nagel S, Talbot NP, Mecinović J, Smith TG, Buchan AM, Schofield CJ. Therapeutic manipulation of the HIF hydroxylases. Antioxidants & Redox Signaling. 12: 481-501. PMID 19754349 DOI: 10.1089/Ars.2009.2711  0.56
2010 Hoyte LC, Buchan AM. Animal Models of Stroke Encyclopedia of Neuroscience. 465-472. DOI: 10.1016/B978-008045046-9.00531-3  0.56
2010 Sideso E, Papadakis M, Wright C, Handa A, Buchan A, Kessler B, Kennedy J. Assessing the quality and reproducibility of a proteomic platform for clinical stroke biomarker discovery Translational Stroke Research. 1: 304-314. DOI: 10.1007/S12975-010-0036-2  0.56
2009 Wu CM, Manns BJ, Hill MD, Ghali WA, Donaldson C, Buchan AM. Rapid evaluation after high-risk TIA is associated with lower stroke risk Canadian Journal of Neurological Sciences. 36: 450-455. PMID 19650355 DOI: 10.1017/S0317167100007770  0.56
2009 Steffenhagen N, Hill MD, Poppe AY, Buchan AM, Coutts SB. Should you thrombolyze all or any stroke patients with baseline national institutes of health stroke scale scores ≤5? Cerebrovascular Diseases. 28: 201-202. PMID 19571531 DOI: 10.1159/000226579  0.56
2009 Haljan G, Maitland A, Buchan A, Arora RC, King M, Haigh J, Culleton B, Faris P, Zygun D. The erythropoietin neuroprotective effect: Assessment in cabg surgery (tenpeaks): A randomized, double-blind, placebo controlled, proof-of-concept clinical trial Stroke. 40: 2769-2775. PMID 19556536 DOI: 10.1161/Strokeaha.109.549436  0.56
2009 Bath PM, Gray LJ, Bath AJ, Buchan A, Miyata T, Green AR. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. British Journal of Pharmacology. 157: 1157-71. PMID 19422398 DOI: 10.1111/J.1476-5381.2009.00196.X  0.56
2009 Poppe AY, Buchan AM, Hill MD. Intravenous thrombolysis for acute ischaemic atroke in young adult patients Canadian Journal of Neurological Sciences. 36: 161-167. PMID 19378708 DOI: 10.1017/S031716710012027X  0.56
2009 Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. International Journal of Stroke : Official Journal of the International Stroke Society. 4: 3-5. PMID 19236488 DOI: 10.1111/J.1747-4949.2009.00241.X  0.56
2009 Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis Diabetes Care. 32: 617-622. PMID 19131465 DOI: 10.2337/Dc08-1754  0.56
2009 Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 221-3. PMID 18797473 DOI: 10.1038/Jcbfm.2008.101  0.56
2009 Papadakis M, Buchan A. Approaches to neuroprotective and reperfusion injury therapy Handbook of Clinical Neurology / Edited by P.J. Vinken and G.W. Bruyn. 94: 1205-1223. PMID 18793896 DOI: 10.1016/S0072-9752(08)94059-8  0.56
2009 Chen LK, McClaran J, Buchan AM. Impact of acute stroke unit on hospital length of stay Archives of Gerontology and Geriatrics. 49: e12-e15. PMID 18789547 DOI: 10.1016/J.Archger.2008.07.008  0.56
2009 Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K, Donnan GA, Howells DW. Good laboratory practice: preventing introduction of bias at the bench. Stroke; a Journal of Cerebral Circulation. 40: e50-2. PMID 18703798 DOI: 10.1161/Strokeaha.108.525386  0.56
2008 Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM, Fischer K, Kenney C, Ryckborst K, McClelland M, Cole-Haskayne A, Newcommon N, Werdal K, Krol A, et al. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke International Journal of Stroke. 3: 3-10. PMID 18705908 DOI: 10.1111/J.1747-4949.2008.00182.X  0.56
2008 Reckless I, Nagel S, Buchan A. Setting up an acute stroke service International Journal of Stroke. 3: 182-187. PMID 18705897 DOI: 10.1111/J.1747-4949.2008.00197.X  0.56
2008 MacEwen C, Ward M, Buchan A. A case of cocaine-induced basilar artery thrombosis Nature Clinical Practice Neurology. 4: 622-626. PMID 18679392 DOI: 10.1038/Ncpneuro0879  0.56
2008 Nagel S, Papadakis M, Hoyte L, Buchan AM. Therapeutic hypothermia in experimental models of focal and global cerebral ischemia and intracerebral hemorrhage Expert Review of Neurotherapeutics. 8: 1255-1268. PMID 18671669 DOI: 10.1586/14737175.8.8.1255  0.56
2008 Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: Of CASES, controls, and treatment-effect modification Neurology. 71: 1080-1083. PMID 18495951 DOI: 10.1161/Strokeaha.107.100001  0.56
2008 Muangpaisan W, Hinkle JL, Westwood M, Kennedy J, Buchan AM. Stroke in the very old: Clinical presentations and outcomes Age and Ageing. 37: 473-475. PMID 18448466 DOI: 10.1093/Ageing/Afn210  0.56
2008 Papadakis M, Nagel S, Buchan AM. Development and efficacy of NXY-059 for the treatment of acute ischemic stroke Future Neurology. 3: 229-240. DOI: 10.2217/14796708.3.3.229  0.56
2008 Karperien AL, Jelinek HF, Buchan AM. Box-counting analysis of microglia form in schizophrenia, alzheimer's disease and affective disorder Fractals. 16: 103-107. DOI: 10.1142/S0218348X08003880  0.56
2008 Kennedy J, Hill MD, Buchan AM. Interpretation of ESPRIT in the FASTER trial - Authors' reply The Lancet Neurology. 7: 199. DOI: 10.1016/S1474-4422(08)70031-0  0.56
2008 Papadakis M, Buchan A. Chapter 59 Approaches to neuroprotective and reperfusion injury therapy Handbook of Clinical Neurology. 94: 1205-1223. DOI: 10.1016/S0072-9752(08)94059-8  0.56
2008 Jelinek H, Karperien A, Buchan A, Bossomaier T. Differentiating grades of microglial activation with fractal analysis Complexity International. 12: 1-12.  0.56
2007 Kennedy J, Buchan AM. Moving forward with intra-arterial and intravenous stroke treatment International Journal of Stroke. 2: 45-46. PMID 18705987 DOI: 10.1111/J.1747-4949.2007.00084.X  0.56
2007 Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial Lancet Neurology. 6: 961-969. PMID 17931979 DOI: 10.1016/S1474-4422(07)70250-8  0.56
2007 Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke Neurology. 68: 1020-1024. PMID 17389306 DOI: 10.1212/01.Wnl.0000257817.29883.48  0.56
2007 Buchan AM, Kennedy J. Strategies for therapy in acute ischemic stroke Nature Clinical Practice Neurology. 3: 2-3. PMID 17205064 DOI: 10.1038/Ncpneuro0393  0.56
2007 Sun HS, Feng ZP, Barber PA, Buchan AM, French RJ. Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo. Neuroscience. 144: 1509-15. PMID 17175112 DOI: 10.1016/J.Neuroscience.2006.10.043  0.56
2007 Dzialowski I, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry Stroke. 38: 75-79. PMID 17122437 DOI: 10.1161/01.Str.0000251644.76546.62  0.56
2007 Buchan AM, Hill MD. Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke? Commentary Nature Clinical Practice Cardiovascular Medicine. 4: 356-357. DOI: 10.1038/Ncpcardio0912  0.56
2007 Ning MM, Montaner J, Wang X, Lee SR, Tsuji K, Tejima E, Buchan AM, Lo EH. Matrix metalloproteinases and tissue plasminogen activator reperfusion therapy for stroke Handbook of Neurochemistry and Molecular Neurobiology: Acute Ischemic Injury and Repair in the Nervous System. 269-286. DOI: 10.1007/978-0-387-30383-3_15  0.56
2006 Papadakis M, Buchan AM. Translational vehicles for neuroprotection Biochemical Society Transactions. 34: 1318-1322. PMID 17073811 DOI: 10.1042/Bst0341318  0.56
2006 Hoyte LC, Papadakis M, Barber PA, Buchan AM. Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning Brain Research. 1121: 231-237. PMID 17010948 DOI: 10.1016/J.Brainres.2006.08.107  0.56
2006 Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke Lancet Neurology. 5: 755-768. PMID 16914404 DOI: 10.1016/S1474-4422(06)70545-2  0.56
2006 Weir NU, Pexman JHW, Hill MD, Buchan AM. How well does ASPECTS predict the outcome of acute stroke treated with IV tPA? Neurology. 67: 516-518. PMID 16894120 DOI: 10.1212/01.Wnl.0000228221.44334.73  0.56
2006 Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, Higashida RT, Fischbein NJ, Dillon WP, Gent M, Firszt CM, Schulz GA, Furlan AJ. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke; a Journal of Cerebral Circulation. 37: 2322-5. PMID 16888269 DOI: 10.1161/01.Str.0000237060.21472.47  0.56
2006 Papadakis M, Buchan AM. NXY-059: Brain or vessel protection Stroke. 37: 2189-2190. PMID 16809574 DOI: 10.1161/01.Str.0000230598.31774.7A  0.56
2006 Pettersen JA, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD. Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3 h of onset Journal of Neurology, Neurosurgery and Psychiatry. 77: 885-887. PMID 16788017 DOI: 10.1136/Jnnp.2005.087494  0.56
2006 Tomanek AI, Coutts SB, Demchuk AM, Hudon ME, Morrish WE, Sevick RJ, Simon JE, Frayne R, Buchan AM, Hill MD. MR angiography compared to conventional selective angiography in acute stroke. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 33: 58-62. PMID 16583723 DOI: 10.1017/S0317167100004704  0.56
2006 Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. The Lancet. Neurology. 5: 323-31. PMID 16545749 DOI: 10.1016/S1474-4422(06)70408-2  0.56
2006 Zhao Z, Sun P, Chauhan N, Kaur J, Hill MD, Papadakis M, Buchan AM. Neuroprotection and neurogenesis: Modulation of cornus ammonis 1 neuronal survival after transient forebrain ischemia by prior fimbria-fornix deafferentation Neuroscience. 140: 219-226. PMID 16542783 DOI: 10.1016/J.Neuroscience.2006.02.011  0.56
2006 Ramasubbu R, Tobias R, Buchan AM, Bech-Hansen NT. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression Journal of Neuropsychiatry and Clinical Neurosciences. 18: 96-99. PMID 16525076 DOI: 10.1176/Jnp.18.1.96  0.56
2006 Chen LK, Buchan AM, Hwang SJ, Hinkle J. Cataract surgery after acute stroke: Maybe more than a coincidence [10] Stroke. 37: 766-767. PMID 16505344 DOI: 10.1161/01.Str.0000204088.04384.74  0.56
2006 Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study Journal of Neurology, Neurosurgery and Psychiatry. 77: 826-829. PMID 16505004 DOI: 10.1136/Jnnp.2005.086595  0.56
2006 Kaur J, Zhao Z, Geransar RM, Papadakis M, Buchan AM. Prior deafferentation confers long term protection to CA1 against transient forebrain ischemia and sustains GluR2 expression Brain Research. 1075: 201-212. PMID 16480690 DOI: 10.1016/J.Brainres.2005.12.123  0.56
2006 Buchan AM. Acute stroke treatment: The end of the first decade Practical Neurology. 6: 338-340. DOI: 10.1136/Jnnp.2006.106427  0.56
2006 Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention | İnmeden korunma Sendrom. 18: 26-30.  0.56
2005 Pettersen JA, Hill MD, Demchuk AM, Morrish W, Hudon ME, Hu W, Wong J, Barber PA, Buchan AM. Intra-arterial thrombolysis for retinal artery occlusion: The calgary experience Canadian Journal of Neurological Sciences. 32: 507-511. PMID 16408583 DOI: 10.1017/S0317167100004522  0.56
2005 Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1528-33. PMID 16227545 DOI: 10.1136/Jnnp.2004.059261  0.56
2005 Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients Stroke. 36: 2072-2076. PMID 16179564 DOI: 10.1161/01.Str.0000183623.28144.32  0.56
2005 Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging Annals of Neurology. 57: 848-854. PMID 15929051 DOI: 10.1002/Ana.20497  0.56
2005 Weir NU, Buchan AM. A study of the workload and effectiveness of a comprehensive acute stroke service Journal of Neurology, Neurosurgery and Psychiatry. 76: 863-865. PMID 15897513 DOI: 10.1136/Jnnp.2004.053462  0.56
2005 Simon JE, Bristow MS, Lu H, Lauzon ML, Brown RA, Manjón JV, Eliasziw M, Frayne R, Buchan AM, Demchuk AM, Mitchell JR. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 1236-43. PMID 15889045 DOI: 10.1038/Sj.Jcbfm.9600130  0.56
2005 Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for Stroke Effectiveness Study Cmaj. 172: 1307-1312. PMID 15883405 DOI: 10.1503/Cmaj.1041561  0.56
2005 Sivakumar C, Palumbo V, Hill MD, Buchan AM, Bravata DM, Rosenbaum JR, Concato J, Brass LM, Kim N, Fried TR. Informed consent for thrombolytic therapy in acute ischemic stroke [3] (multiple letters) Stroke. 36: 528-529. PMID 15738575 DOI: 10.1161/01.Str.0000154854.92922.03  0.56
2005 Boulanger JM, Coutts SB, Hill MD, Demchuk AM, Buchan AM, Purroy F, Montaner J, Delgado P, Álvarez-Sabín J. Use of magnetic resonance imaging in predicting further vascular events among patients with transient ischemic attacks [2] (multiple letters) Stroke. 36: 526-528. PMID 15738574 DOI: 10.1161/01.Str.0000154859.25903.75  0.56
2005 Kennedy J, Buchan AM. C-EPO: Ready for prime-time preconditioning? Cerebrovascular Diseases. 19: 272-273. PMID 15731559 DOI: 10.1159/000084140  0.56
2005 Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention: MATCHing therapy to the patient with TIA Postgraduate Medicine. 117: 26-30. PMID 15672888 DOI: 10.3810/Pgm.2005.01.1566  0.56
2004 Simon JE, Czechowsky DK, Hill MD, Harris AD, Buchan AM, Frayne R. Fluid-attenuated inversion recovery preparation: not an improvement over conventional diffusion-weighted imaging at 3T in acute ischemic stroke. Ajnr. American Journal of Neuroradiology. 25: 1653-8. PMID 15569726  0.56
2004 Coutts SB, Lev MH, Eliasziw M, Roccatagliata L, Hill MD, Schwamm LH, Pexman JH, Koroshetz WJ, Hudon ME, Buchan AM, Gonzalez RG, Demchuk AM. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke; a Journal of Cerebral Circulation. 35: 2472-6. PMID 15486327 DOI: 10.1161/01.Str.0000145330.14928.2A  0.56
2004 Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke Stroke. 35: 2726-2730. PMID 15459442 DOI: 10.1161/01.Str.0000143219.16695.Af  0.56
2004 Barber PA, Demchuk AM, Hill MD, Pexman JH, Hudon ME, Frayne R, Buchan AM. The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1426-30. PMID 15377690 DOI: 10.1136/Jnnp.2003.029389  0.56
2004 Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? Journal of Cerebral Blood Flow and Metabolism. 24: 945-963. PMID 15356416 DOI: 10.1097/01.Wcb.0000137868.50767.E8  0.56
2004 Hoyte L, Kaur J, Buchan AM. Lost in translation: Taking neuroprotection from animal models to clinical trials Experimental Neurology. 188: 200-204. PMID 15246820 DOI: 10.1016/J.Expneurol.2004.05.008  0.56
2004 Barber PA, Foniok T, Kirk D, Buchan AM, Laurent S, Boutry S, Muller RN, Hoyte L, Tomanek B, Tuor UI. MR molecular imaging of early endothelial activation in focal ischemia Annals of Neurology. 56: 116-120. PMID 15236408 DOI: 10.1002/Ana.20162  0.56
2004 Barber PA, Hoyte L, Colbourne F, Buchan AM. Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke; a Journal of Cerebral Circulation. 35: 1720-5. PMID 15155973 DOI: 10.1161/01.Str.0000129653.22241.D7  0.56
2004 Coutts SB, Demchuk AM, Barber PA, Hu WY, Simon JE, Buchan AM, Hill MD. Interobserver variation of ASPECTS in real time Stroke; a Journal of Cerebral Circulation. 35: e103-105. PMID 15073381 DOI: 10.1161/01.Str.0000127082.19473.45  0.56
2004 Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 170: 1105-9. PMID 15051694 DOI: 10.1503/Cmaj.1030460  0.56
2004 Pexman JHW, Hill MD, Buchan AM, Demchuk AM, Barber PA, Simon JE, Coutts SB, Saur D, Röther J, Kucinski T. Hyperacute Stroke: Experience Essential When Reading Unenhanced CT Scans American Journal of Neuroradiology. 25: 516-518. PMID 15037484  0.56
2004 Hoyte L, Barber PA, Buchan AM, Hill MD. The rise and fall of NMDA antagonists for ischemic stroke Current Molecular Medicine. 4: 131-136. PMID 15032709 DOI: 10.2174/1566524043479248  0.56
2004 Simon JE, Sandler DL, Pexman JHW, Hill MD, Buchan AM. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience Age and Ageing. 33: 143-149. PMID 14960429 DOI: 10.1093/Ageing/Afh031  0.56
2004 Di Legge S, Beletsky V, Jain V, Hachinski V, Simon JE, Morgan SC, Pexman JHW, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke [1] (multiple letters) Neurology. 62: 523. PMID 14872055  0.56
2004 Kennedy J, Buchan AM. Acute Neurovascular Syndromes: Hurry Up, Please, It's Time Stroke. 35: 360-362. PMID 14757879 DOI: 10.1161/01.Str.0000115260.19243.64  0.56
2004 Coutts SB, Barber PA, Demchuk AM, Hill MD, Pexman JHW, Hudon ME, Buchan AM. Mild Neurological Symptoms Despite Middle Cerebral Artery Occlusion Stroke. 35: 469-471. PMID 14726548 DOI: 10.1161/01.Str.0000110985.01773.7F  0.56
2004 Kennedy J, Ma C, Buchan AM. Organization of regional and local stroke resources: Methods to expedite acute management of stroke Current Neurology and Neuroscience Reports. 4: 13-18. PMID 14683622 DOI: 10.1007/S11910-004-0005-9  0.56
2003 Coutts SB, Hill MD, Demchuk AM, Barber PA, Pexman JHW, Buchan AM. ASPECTS reading requires training and experience Stroke; a Journal of Cerebral Circulation. 34: e179; author reply e. PMID 12970512 DOI: 10.1161/01.Str.0000092221.81498.91  0.56
2003 Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke; a Journal of Cerebral Circulation. 34: 1925-31. PMID 12843342 DOI: 10.1161/01.Str.0000082483.37127.D0  0.56
2003 Coutts SB, Simon JE, Tomanek AI, Barber PA, Chan J, Hudon ME, Mitchell JR, Frayne R, Eliasziw M, Buchan AM, Demchuk AM. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke; a Journal of Cerebral Circulation. 34: 1681-3. PMID 12805485 DOI: 10.1161/01.Str.0000078840.96473.20  0.56
2003 Barber PA, Demchuk AM, Hirt L, Buchan AM. Biochemistry of ischemic stroke Advances in Neurology. 92: 151-164. PMID 12760178  0.56
2003 Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, Green TL, Kenney C, Cole-Haskayne A, Buchan AM. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke Neurology. 60: 1525-1527. PMID 12743244 DOI: 10.1212/01.Wnl.0000058840.66596.1A  0.56
2003 Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, Mitchell LB, Shuaib A, Teo KK, Tsuyuki RT. The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. The Canadian Journal of Cardiology. 19: 280-4. PMID 12677283  0.56
2003 Watson TW, Simon JE, Buchan AM. Stroke care: the way forward. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 411-2. PMID 12640048 DOI: 10.1136/Jnnp.74.4.411  0.56
2003 Colbourne F, Grooms SY, Zukin RS, Buchan AM, Bennett MV. Hypothermia rescues hippocampal CA1 neurons and attenuates down-regulation of the AMPA receptor GluR2 subunit after forebrain ischemia. Proceedings of the National Academy of Sciences of the United States of America. 100: 2906-10. PMID 12606709 DOI: 10.1073/Pnas.2628027100  0.56
2003 Kennedy J, Buchan AM. Ever decreasing circles: Advances in antiplatelet therapy and anticoagulation Stroke. 34: 348-350. PMID 12574532 DOI: 10.1161/01.Str.0000054264.39521.56  0.56
2003 Chauhan N, Zhao Z, Barber PA, Buchan AM. Lessons in experimental ischemia for clinical stroke medicine Current Opinion in Neurology. 16: 65-71. PMID 12544859 DOI: 10.1097/01.Wco.0000053588.70044.5A  0.56
2003 Menniti FS, Buchan AM, Chenard BL, Critchett DJ, Ganong AH, Guanowsky V, Seymour PA, Welch WM. CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo Stroke. 34: 171-176. PMID 12511770 DOI: 10.1161/01.STR.0000048216.90221.9C  0.56
2003 Simon JE, Kennedy J, Pexman JHW, Buchan AM. The eyes have it: Conjugate eye deviation on CT scan aids in early detection of ischemic stroke Cmaj. 168: 1446-1447.  0.56
2002 Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR, Hamilton SA, Hanson SK, Grotta JC, Morgenstern L, Krieger D, Villar C, Chiu D, Wein T, ... ... Buchan AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA acute stroke survey Circulation. 105: 1679-1685. PMID 11940547 DOI: 10.1161/01.CIR.0000012747.53592.6A  0.56
2002 Hill MD, Barber PA, Demchuk AM, Newcommon NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick RJ, Buchan AM. Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke. Stroke; a Journal of Cerebral Circulation. 33: 279-82. PMID 11779923 DOI: 10.1161/Hs0102.101900  0.56
2001 Fink JN, Selim MH, Kumar S, Schlaug G. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology. 57: 1739-40. PMID 11706134 DOI: 10.1212/Wnl.57.9.1739  0.56
2001 Kennedy J, Buchan AM, Barnett HJ. Thrombolysis must be considered after stroke. Bmj (Clinical Research Ed.). 323: 937. PMID 11668151 DOI: 10.1136/Bmj.323.7318.937/B  0.56
2001 Pexman JHW, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke American Journal of Neuroradiology. 22: 1534-1542. PMID 11559501  0.56
2001 Bungard TJ, Ghali WA, McAlister FA, Buchan AM, Cave AJ, Hamilton PG, Mitchell LB, Shuaib A, Teo KK, Tsuyuki RT. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 165: 301-2. PMID 11517646  0.56
2001 Hill MD, Buchan AM. Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES) Canadian Journal of Neurological Sciences. 28: 232-238. PMID 11513342 DOI: 10.1017/S0317167100001384  0.56
2001 Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat Brain Research. 909: 46-50. PMID 11478919 DOI: 10.1016/S0006-8993(01)02618-X  0.56
2001 Barber PA, Auer RN, Buchan AM, Sutherland GR. Understanding and managing ischemic stroke. Canadian Journal of Physiology and Pharmacology. 79: 283-96. PMID 11294605 DOI: 10.1139/Y00-125  0.56
2001 Buchan AM, Warren D, Burnstein R, Kondziolka D. Transplantation of cultured human neuronal cells for patients with stroke [2] Neurology. 56: 821-822. PMID 11274333  0.56
2001 Hill MD, Barber PA, Demchuk AM, Sevick RJ, Frayne R, Buchan AM. Symptomatic hemorrhage after alteplase therapy not due to silent ischemia. Bmc Neurology. 1: 1. PMID 11208259 DOI: 10.1186/1471-2377-1-1  0.56
2001 Li H, Klein G, Sun P, Buchan AM. Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia Brain Research. 888: 263-266. PMID 11150483 DOI: 10.1016/S0006-8993(00)03077-8  0.56
2001 Barber PA, Demchuk AM, Hudon ME, Warwick Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia Stroke. 32: 84-88. PMID 11136919 DOI: 10.1161/01.Str.32.1.84  0.56
2001 Hill MD, Gubitz GJ, Phillips SJ, Buchan AM. The CAEP Position Statement: Another perspective Canadian Journal of Emergency Medicine. 3: 180-182.  0.56
2000 Buchan AM, Feasby TE. Stroke thrombolysis: Is tissue plasminogen activator a defibrillator for the brain? Cmaj. 162: 47-48. PMID 11216198  0.56
2000 Colbourne F, Corbett D, Zhao Z, Yang J, Buchan AM. Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 1702-8. PMID 11129786 DOI: 10.1097/00004647-200012000-00009  0.56
2000 Barber PA, Hill MD, Demchuk AM, Buchan AM. Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke? Canadian Journal of Neurological Sciences. 27: 283-287. PMID 11097516 DOI: 10.1017/S0317167100001001  0.56
2000 MacManus JP, Buchan AM. Apoptosis after experimental stroke: Fact or fashion? Journal of Neurotrauma. 17: 899-914. PMID 11063056 DOI: 10.1089/Neu.2000.17.899  0.56
2000 Nawashiro H, Fukui S, Barber PA, Demchuk AM, Buchan AM. Intra-arterial thrombolysis for hyperacute stroke [5] (multiple letters) Lancet. 356: 1111-1112. PMID 11009167  0.56
2000 Li H, Klein G, Sun P, Buchan AM. CoQ10 fails to protect brain against focal and global ischemia in rats Brain Research. 877: 7-11. PMID 10980237 DOI: 10.1016/S0006-8993(00)02609-3  0.56
2000 Hill MD, Barber PA, Demchuk AM, Buchan AM, Bath P, Bath F, Rashid P, Weaver C. Acute ischaemic stroke (multiple letters) British Medical Journal. 321: 299-300. PMID 10979695  0.56
2000 Chodirker WB, Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Reactions to alteplase in patients with acute thrombotic stroke [2] (multiple letters) Cmaj. 163: 387-389. PMID 10976251  0.56
2000 Buchan AM. Can pure oxygen prevent stroke damage? Critical Care Medicine. 28: 3101. PMID 10966313 DOI: 10.1097/00003246-200008000-00081  0.56
2000 Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy Lancet. 355: 1670-1674. PMID 10905241 DOI: 10.1016/S0140-6736(00)02237-6  0.56
2000 Barnett HJ, Buchan AM. The imperative to develop dedicated stroke centers. Jama. 283: 3125-6. PMID 10865309 DOI: 10.1001/Jama.283.23.3125  0.56
2000 Hill MD, Barber PA, Demchuk AM, Sevick RJ, Newcommon NJ, Green T, Buchan AM. Building a 'brain attack' team to administer thrombolytic therapy for acute ischemic stroke Cmaj. 162: 1589-1593. PMID 10862236  0.56
2000 Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke Cmaj. 162: 1281-1284. PMID 10813008  0.56
2000 Demchuk AM, Buchan AM. Predictors of stroke outcome Neurologic Clinics. 18: 455-473. PMID 10757836 DOI: 10.1016/S0733-8619(05)70202-4  0.56
2000 Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness Neurology. 54: 679-684. PMID 10680803 DOI: 10.1212/Wnl.54.3.679  0.56
2000 Buchan AM, Li H, Blackburn B. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-κB activation Neuroreport. 11: 427-430. PMID 10674500 DOI: 10.1097/00001756-200002070-00041  0.56
2000 Hara A, Mori H, Niwa M, Colbourne F, Li H, Buchan AM. Novel apoptotic evidence for delayed neuronal death in the hippocampal CA1 pyramidal cells after transient ischemia [6] (multiple letters) Stroke. 31: 236-238. PMID 10625744 DOI: 10.1161/01.STR.31.1.231-E  0.56
2000 Li H, Colbourne F, Sun P, Zhao Z, Buchan AM, Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke; a Journal of Cerebral Circulation. 31: 176-82. PMID 10625735 DOI: 10.1161/01.Str.31.1.176  0.56
2000 Verbeek R, Buchan AM, Feasby TE. Treating stroke [1] (multiple letters) Cmaj. 162: 1273-1274.  0.56
2000 Hill MD, Barber PA, Demchuk AM, Buchan AM. Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke Today's Therapeutic Trends. 18: 285-304.  0.56
1999 Colbourne F, Li H, Buchan AM. Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 742-9. PMID 10413028 DOI: 10.1097/00004647-199907000-00003  0.56
1999 Colbourne F, Li H, Buchan AM, Clemens JA. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke; a Journal of Cerebral Circulation. 30: 662-8. PMID 10066868 DOI: 10.1161/01.Str.30.3.662  0.56
1997 Lingenhöhl K, Small DL, Monette R, Buchan AM, Morley P, Allegrini PR, Fröst LW, Sauer D, Schmutz M, Knöpfel T. Exploration of P-type Ca2+ channels as drug targets for the treatment of epilepsy or ischemic stroke. Neuropharmacology. 36: 107-13. PMID 9144647 DOI: 10.1016/S0028-3908(96)00158-X  0.56
1995 Murkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery:. II. neurologic and cognitive outcomes The Journal of Thoracic and Cardiovascular Surgery. 110: 349-362. PMID 7637352 DOI: 10.1016/S0022-5223(95)70230-X  0.56
1995 Murkin JM, Martzke JS, Buchan AM, Bentley C, Wong CJ. A randomized study of the influence of perfusion technique and pH management strategy in 316 patients undergoing coronary artery bypass surgery:. I. mortality and cardiovascular morbidity The Journal of Thoracic and Cardiovascular Surgery. 110: 340-348. PMID 7637351 DOI: 10.1016/S0022-5223(95)70229-6  0.56
1994 Takizawa S, Hogan MJ, Buchan AM, Hakim AM. In vivo binding of [3H]nimodipine in rat brain after transient forebrain ischemia Journal of Cerebral Blood Flow and Metabolism. 14: 397-405. PMID 8163582 DOI: 10.1038/Jcbfm.1994.51  0.56
1991 Buchan AM, Xue D, Huang ZG, Smith KH, Lesiuk H. Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport. 2: 473-6. PMID 1655110 DOI: 10.1097/00001756-199108000-00016  0.56
Show low-probability matches.